Julius Leyton

2.7k total citations · 1 hit paper
47 papers, 2.1k citations indexed

About

Julius Leyton is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Julius Leyton has authored 47 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 17 papers in Cellular and Molecular Neuroscience and 10 papers in Oncology. Recurrent topics in Julius Leyton's work include Neuropeptides and Animal Physiology (17 papers), Receptor Mechanisms and Signaling (10 papers) and Fatty Acid Research and Health (6 papers). Julius Leyton is often cited by papers focused on Neuropeptides and Animal Physiology (17 papers), Receptor Mechanisms and Signaling (10 papers) and Fatty Acid Research and Health (6 papers). Julius Leyton collaborates with scholars based in United States, United Kingdom and Israel. Julius Leyton's co-authors include Michael A. Crawford, Patrick Drury, Terry W. Moody, Eric O. Aboagye, Robert T. Jensen, Meg Perumal, Luis García, Alfredo Martı́nez, J. Zahavi and James L. Mulshine and has published in prestigious journals such as American Journal of Clinical Nutrition, Cancer Research and Annals of the New York Academy of Sciences.

In The Last Decade

Julius Leyton

47 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Differential oxidation of saturated and unsaturated fatty acids in vivo in the rat

1987 464 citations Julius Leyton, Michael A. Crawford et al. profile →

Peers

Julius Leyton

ONCOL

RNMI

CMN

John Woods United States

U. Karbach Germany

Evelyn F. Grollman United States

Andrey Sorokin United States

Osamu Nakajima Japan

Max Fehlmann France

Bernard Desbuquois France

M P Czech United States

Jane McHowat United States

Gary V. Richieri United States

John Woods United States

Julius Leyton

1.7k ×2.2

502 ×1.2

ONCOL

188 ×0.5

92 ×0.2

RNMI

299 ×0.9

CMN

Citations per year, relative to Julius Leyton Julius Leyton (= 1×) peers John Woods

Countries citing papers authored by Julius Leyton

Since Specialization

Citations

This map shows the geographic impact of Julius Leyton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julius Leyton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julius Leyton more than expected).

Fields of papers citing papers by Julius Leyton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julius Leyton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julius Leyton. The network helps show where Julius Leyton may publish in the future.

Co-authorship network of co-authors of Julius Leyton

This figure shows the co-authorship network connecting the top 25 collaborators of Julius Leyton. A scholar is included among the top collaborators of Julius Leyton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julius Leyton. Julius Leyton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Laverman, Peter, Lieke Joosten, Maggie Cooper, et al.. (2014). PET and SPECT Imaging of a Radiolabeled Minigastrin Analogue Conjugated with DOTA, NOTA, and NODAGA and Labeled with ⁶⁴Cu, ⁶⁸Ga, and ¹¹¹In. Molecular Pharmaceutics. 11(11). 3930–3937. 62 indexed citations

Leyton, Julius, Bård Indrevoll, Matthias Glaser, et al.. (2011). Synthesis and in vitro evaluation of [18F]fluoroethyl triazole labelled [Tyr3]octreotate analogues using click chemistry. Bioorganic & Medicinal Chemistry Letters. 21(10). 3122–3127. 37 indexed citations

Leyton, Julius, Graham Smith, Yongjun Zhao, et al.. (2009). [18F]Fluoromethyl-[1,2-2H4]-Choline: A Novel Radiotracer for Imaging Choline Metabolism in Tumors by Positron Emission Tomography. Cancer Research. 69(19). 7721–7728. 30 indexed citations

Leyton, Julius, et al.. (2009). Validation of a Spectrophotometric Method for Quantification of Carboxyhemoglobin. Journal of Analytical Toxicology. 33(8). 540–544. 16 indexed citations

Pillai, Radhakrishna G., Martin Förster, Meg Perumal, et al.. (2008). Imaging Pharmacodynamics of the α-Folate Receptor–Targeted Thymidylate Synthase Inhibitor BGC 945. Cancer Research. 68(10). 3827–3834. 30 indexed citations

Leyton, Julius, Graham Smith, Meg Perumal, et al.. (2008). Noninvasive imaging of cell proliferation following mitogenic extracellular kinase inhibition by PD0325901. Molecular Cancer Therapeutics. 7(9). 3112–3121. 41 indexed citations

Leyton, Julius, Michelle Lockley, Joeri L. Aerts, et al.. (2006). Quantifying the Activity of Adenoviral E1A CR2 Deletion Mutants Using Renilla Luciferase Bioluminescence and 3′-Deoxy-3′-[18F]Fluorothymidine Positron Emission Tomography Imaging. Cancer Research. 66(18). 9178–9185. 23 indexed citations

Moody, Terry W., Julius Leyton, Luis García, & Robert T. Jensen. (2003). Nonpeptide gastrin releasing peptide receptor antagonists inhibit the proliferation of lung cancer cells. European Journal of Pharmacology. 474(1). 21–29. 38 indexed citations

Wang, Y., Michael A. Crawford, Junshi Chen, et al.. (2003). Fish consumption, blood docosahexaenoic acid and chronic diseases in Chinese rural populations. Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology. 136(1). 127–140. 33 indexed citations

10.

Leyton, Julius, Luis García, Robert T. Jensen, & Terry W. Moody. (2002). Neurotensin causes tyrosine phosphorylation of focal adhesion kinase in lung cancer cells. European Journal of Pharmacology. 442(3). 179–186. 28 indexed citations

11.

Moody, Terry W., et al.. (2002). PACAP-27 tyrosine phosphorylates mitogen activated protein kinase and increases VEGF mRNAs in human lung cancer cells. Regulatory Peptides. 109(1-3). 135–140. 23 indexed citations

12.

Leyton, Julius, Luis García, José A. Tapia, Robert T. Jensen, & Terry W. Moody. (2001). Bombesin and gastrin releasing peptide increase tyrosine phosphorylation of focal adhesion kinase and paxillin in non-small cell lung cancer cells. Cancer Letters. 162(1). 87–95. 29 indexed citations

13.

Moody, Terry W., Julius Leyton, Farah Zia, et al.. (2000). Thymosinα1 is chemopreventive for lung adenoma formation in A/J mice. Cancer Letters. 155(2). 121–127. 18 indexed citations

14.

Moody, Terry W., Robert T. Jensen, Luis García, & Julius Leyton. (2000). Nonpeptide neuromedin B receptor antagonists inhibit the proliferation of C6 cells. European Journal of Pharmacology. 409(2). 133–142. 24 indexed citations

15.

Moody, Terry W., Julius Leyton, & Christy S. John. (2000). Sigma ligands inhibit the growth of small cell lung cancer cells. Life Sciences. 66(20). 1979–1986. 32 indexed citations

16.

Koh, Shay‐Whey M., Julius Leyton, & Terry W. Moody. (1999). Bombesin activates MAP kinase in non-small cell lung cancer cells. Peptides. 20(1). 121–126. 22 indexed citations

17.

Leyton, Julius, et al.. (1998). PACAP(6–38) inhibits the growth of prostate cancer cells. Cancer Letters. 125(1-2). 131–139. 31 indexed citations

18.

Moody, Terry W., Julius Leyton, Edward J. Unsworth, et al.. (1998). (Arg15, Arg21) VIP: Evaluation of Biological Activity and Localization to Breast Cancer Tumors. Peptides. 19(3). 585–592. 39 indexed citations

19.

Pisegna, Joseph R., Julius Leyton, Toyoaki Hida, et al.. (1997). PACAP hybrid: A new PACAP receptor antagonist. Life Sciences. 61(6). 631–639. 14 indexed citations

20.

Moody, Terry W., Julius Leyton, Sonia B. Jakowlew, et al.. (1997). (Stearyl, Norleucine17) VIP hybrid antagonizes VIP receptors on non-small cell lung cancer cells. Life Sciences. 61(17). 1657–1666. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact